Therefore, future research should focus on identifying miRNAs that modulate the AQP5/NF-κB axis in colorectal cancer, with the aim of developing small RNA-based therapeutics to reverse chemotherapy resistance and improve treatment outcomes. Here, NFKB1 is linked to colorectal cancer.